Organometallic compounds in oncology: implications of novel organotins as antitumor agents.

Volume: 14, Issue: 9, Pages: 500 - 508
Published: May 1, 2009
Abstract
Since the introduction of cisplatin in cancer therapy, metal complexes and organometallic compounds have been gaining growing importance in oncology. The impressive clinical effectiveness of cisplatin is limited by significant side effects and the emergence of drug resistance. Thus, novel classic and unconventional Pt(II) and Pt(IV) complexes have been introduced in therapy or are presently in advanced clinical trials. Moreover, innovative...
Paper Details
Title
Organometallic compounds in oncology: implications of novel organotins as antitumor agents.
Published Date
May 1, 2009
Volume
14
Issue
9
Pages
500 - 508
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.